Two prominent venture capital firms have announced massive fund raises totaling $5.5 billion, signaling strong conviction that AI remains a fertile investment landscape despite significant headwinds elsewhere in tech. Menlo Ventures closed a $3 billion raise across two new funds—its largest capital deployment in 50 years—with explicit focus on AI startups spanning seed through growth stage. Simultaneously, Valor Equity Partners is raising a $2.5 billion Fund VII. Both firms are targeting deployment across enterprise tools and healthcare, sectors where AI adoption is accelerating rapidly and regulatory pathways are becoming clearer.
The aggressive capital deployment comes against the backdrop of over 127,000 tech layoffs in 2025 alone, with cuts persisting into 2026 according to Crunchbase data. This apparent contradiction—mass job losses alongside record VC raises—reflects a strategic reallocation of investment rather than overall contraction. VCs are increasingly confident that infrastructure and AI-native companies will emerge as winners from sector consolidation. Mike Schroepfer, former Meta CTO and founder of Gigascale Capital, recently emphasized that infrastructure itself has become the critical moat, with breakthroughs in power efficiency, batteries, and specialized computing reshaping competitive dynamics.
Healthcare AI is attracting particular attention, exemplified by XCures' $46 million Series B closing led by Innovius Capital. The medical records platform's substantial raise highlights investor appetite for AI solutions addressing real operational inefficiencies in enterprise settings. As generalist tech firms downsize, specialized AI companies solving domain-specific problems with proven unit economics are capturing disproportionate capital inflows, reshaping where venture dollars actually flow regardless of broader tech sector turbulence.